Aiming to improve outcomes for people with certain rare diseases, cancers or neurological conditions
ONCOLOGY
Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at helping patients with cancers of high unmet medical need including those with neuroendocrine tumors, advanced kidney cancer (renal cell carcinoma), liver cancer (hepatocellular carcinoma) and advanced or metastatic, differentiated thyroid cancer.
RARE DISEASE
We continue to evolve and grow our research efforts in the area of rare and ultra-rare diseases. Given the limited understanding of these diseases, we are committed to addressing patient needs, from supporting diagnosis to treatment with specific investment in pituitary pathologies, growth disorders, and ultra-rare bone diseases, including fibrodysplasia ossificans progressiva, commonly known as FOP.
NEUROSCIENCE
People suffering from neurological disorders are in need of treatments, and we’ve become a global leader in creating them through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older, and cervical dystonia in adults.